News
CHICAGO, April 25, 2025--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 ...
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR ...
Bruker Corporation (Nasdaq: BRKR) today announced the launch ofthe Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This ...
Bruker d-DNP polarizer shown (center) at UCSF, between Bruker 9.4T MRI (far left) and Fourier 80 NMR (right of polarizer). The novel d-DNP system enables >10,000x signal gains on 13C in high-field ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer ...
Bruker Corporation is focused on developing, making and distributing scientific instruments, and analytical and diagnostic solutions. Bruker operates out of four main business segments: Bruker ...
Across the recent three months, 6 analysts have shared their insights on Bruker BRKR, expressing a variety of opinions spanning from bullish to bearish. The table below offers a condensed view of ...
Additionally, the AtoMx spatial informatics platform will house new Bruker-trained AI cell segmentation models, extending the platform’s best-in-class definition of single-cell boundaries for accurate ...
Bruker stock opened at $38.70 on Monday. The stock has a 50-day simple moving average of $48.29 and a 200-day simple moving average of $55.79. The company has a market capitalization of $5.87 ...
Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results